Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thiede

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Leukemia|April 4, 2017
Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscapeP Silva, M Neumann, M P Schroeder, et al.
Leukemia|February 12, 2011
Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategyS Tuve, J Gayoso, C Scheid, et al.
Leukemia|February 8, 2014
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantationV Panagiota, F Thol, B Markus, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2026
Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) - an AIO / ABCSG trialG Folprecht, S Stasik, A Reinacher-Schick, et al.
Leukemia|December 2, 2014
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trialJ Schetelig, M Schaich, K Schäfer-Eckart, et al.
Leukemia|March 21, 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5qM Heuser, M Meggendorfer, M M A Cruz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patientsC Röllig, M Kramer, M Gabrecht, et al.
Leukemia|October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approachT Burmeister, J Maurer, M Aivado, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Leukemia|April 4, 2017
Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscapeP Silva, M Neumann, M P Schroeder, et al.
Leukemia|February 12, 2011
Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategyS Tuve, J Gayoso, C Scheid, et al.
Leukemia|February 8, 2014
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantationV Panagiota, F Thol, B Markus, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2026
Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) - an AIO / ABCSG trialG Folprecht, S Stasik, A Reinacher-Schick, et al.
Leukemia|December 2, 2014
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trialJ Schetelig, M Schaich, K Schäfer-Eckart, et al.
Leukemia|March 21, 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5qM Heuser, M Meggendorfer, M M A Cruz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patientsC Röllig, M Kramer, M Gabrecht, et al.
Leukemia|October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approachT Burmeister, J Maurer, M Aivado, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 15